US 12,257,441 B2
Minimally invasive neurostimulation device
Charles Bombeck, Lino Lakes, MN (US); Sarah Offutt, Golden Valley, MN (US); Ryan Bauer, Plymouth, MN (US); Andrew Cleland, St. Paul, MN (US); and Randy S. Roles, Elk River, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Apr. 26, 2023, as Appl. No. 18/307,385.
Application 18/307,385 is a division of application No. 16/947,092, filed on Jul. 17, 2020, granted, now 11,672,991.
Claims priority of provisional application 62/875,089, filed on Jul. 17, 2019.
Prior Publication US 2023/0256254 A1, Aug. 17, 2023
Int. Cl. A61N 1/372 (2006.01); A61B 34/00 (2016.01); A61N 1/05 (2006.01); A61N 1/378 (2006.01)
CPC A61N 1/37235 (2013.01) [A61N 1/0504 (2013.01); A61N 1/0558 (2013.01); A61N 1/378 (2013.01); A61B 2034/252 (2016.02)] 6 Claims
OG exemplary drawing
 
1. A method of implanting a tibial nerve stimulation device in an ankle region of a patient, the tibial nerve stimulation device including a housing and an electrical lead coupled to the housing, the electrical lead offset from the housing and including at least one electrode, a longitudinal axis of the housing generally oriented in the same direction as a longitudinal axis of the electrical lead, the method comprising:
creating a first incision, in a skin of a patient superior and posterior to a medial malleolus on an ankle of the patient;
creating a second incision, in a fascia layer in the ankle of the patient, the second incision being smaller than the first incision and the second incision sized to allow passage of the electrical lead therethrough; and
advancing the implantable tibial nerve stimulation device through the first incision downward towards a heel of the patient and inward such that the electrical lead passes through the second incision, such that the housing of the implantable tibial nerve stimulation device is positioned superficial to the fascia layer and such that the at least one electrode is positioned below the fascia.